| tg66 | tgRM |
---|
Case #a | Subtypeb | PrPSc-M129c | DPId | Clin/totale | DPId | Clin/totale |
---|
Control | MM1 | 100 | 187 ± 13 | 9/9 | 211 ± 11 | 8/8 |
3 | MV1 + 2C | 100 ± 0**** | 196 ± 19 | 8/8 | 218 ± 13 | 7/8 |
4 | MV1 + 2C | 34 ± 5 | >  611 | 0/7 | >  651 | 0/6 |
9 (CC) | MV2K + 2C | 82 ± 8** | >  502 | 0/5 | >  662 | 0/7 |
9 (CbC) | MV2K + 2C | 33 ± 8 | 488 ± 17 | 5/5 | 519 ± 26 | 2/4 |
12 | MV2K + 2C | 29 ± 20 | 497 ± 132 | 2/5 | 471 | 1/7 |
19 (iCJD) | MV2K | 66 ± 4*** | 184 ± 2 | 3/3 | 214 ± 9 | 7/7 |
10 | MV2K | 43 ± 2 | 407 ± 36 | 7/7 | 503 ± 54 | 5/6 |
20 (iCJD) | MV2K | 39 ± 6 | 482 ± 34 | 2/7 | 373 | 1/5 |
7 | MV2K | 38 ± 18 | 398 ± 13 | 6/6 | 448 ± 18 | 4/5 |
18 (iCJD) | MV2K | 36 ± 5 | 238 ± 17 | 5/8 | 296 ± 46 | 4/7 |
11 | MV2C | 85 ± 1 | 401 ± 21 | 2/8 | >  790 | 0/8 |
- aNeuropathological subtype of cases originally described in [28]. All cases are sCJD except where noted as iCJD. CB cerebellar cortex, CC cerebral cortex
- bCases originally described in [28]. MV2K = CJD subtype MV2 with kuru (K) plaques; 2C = Type 2 PrPSc in the cortex
- cPercentage of PrPSc in the inoculum which is PrPSc-M129 shown as mean + standard deviation. Data adapted from [28]. **** p = 0.0001 versus case 4 by unpaired student’s t-test; ***p = 0.02 versus case 10, 0.007 versus case 20, 0.009 versus case 7, and 0.003 versus case 18 using Tukey’s multiple comparisons test; ** p = 0.01 versus case 9 (CbC) and 12 using Tukey’s multiple comparisons test
- dDPI = mean days post-infection + standard deviation
- eNumber of mice with clinical disease over total number of mice inoculated. Intercurrent deaths are not included